Performance analysis of Abeona Therapeutics (ABEO)
Annual Return
Over the past 3 years, ABEO has had an average annual return of +10.08%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, ABEO has had an average annual return of -28.90%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, ABEO has had an average annual return of -20.96%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Nov 1, 1999, ABEO has had an average annual return of -25.37%, underperforming the benchmark SPY, which returned +8.49% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | +0% | +33.33% | +50% | -66.67% | -76.92% | -52.73% | -54.17% | -55.06% | +225.61% | +43.86% | -1.72% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -72.51% | +4.46% | -83.35% | -41.91% | -24.65% | +232.25% | -69.53% | +16.07% | +7.72% | -85.31% | -32.44% | +249.32% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -66.22% | -11.20% | +150.01% | -15.79% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -25.00% | +0% | +0% | +33.33% | +0% | +0% | +0% | +0% | |||||
| 2025 | +0% | +0% | -25.00% | +33.33% | +0% | +0% | +0% | +25% | -20.00% | -25.00% | +0% | +33.33% | +0% |
| 2024 | +0% | +66.67% | +0% | -40.00% | +0% | +0% | +0% | +33.33% | +0% | +0% | +0% | +0% | +33.33% |
| 2023 | +0% | +0% | +0% | +0% | +0% | +50% | -33.33% | +50% | +0% | +0% | +0% | +0% | +50% |
| 2022 | -33.33% | +0% | +25% | -40.00% | +0% | +33.33% | -25.00% | -33.33% | +0% | +50% | +0% | -33.33% | -66.67% |
| 2021 | +23.08% | +28.13% | -21.95% | -6.25% | -6.67% | -7.14% | -19.23% | +4.76% | -13.64% | -26.32% | -14.29% | -50.00% | -76.92% |
| 2020 | -32.73% | +40.54% | -32.69% | +14.29% | +40% | -12.50% | -2.04% | -16.67% | -57.50% | +5.88% | +50% | -3.70% | -52.73% |
| 2019 | -5.00% | +3.51% | +5.08% | +4.84% | -29.23% | -11.96% | -45.68% | -40.91% | +46.15% | +5.26% | +42.50% | -3.51% | -54.17% |
| 2018 | -3.75% | -9.34% | +3.86% | +21.49% | +1.36% | -9.73% | -9.67% | +6.58% | -16.60% | -32.87% | -4.83% | -13.04% | -55.06% |
| 2017 | -6.10% | +18.18% | -7.69% | +13.10% | -5.26% | +20% | +31.48% | +55.63% | +29.86% | +5.23% | -3.64% | -8.25% | +225.61% |
Drawdown analysis of Abeona Therapeutics (ABEO)
The maximum drawdown for the ABEO was -100.00%, occurring on May 11, 2022. This drawdown has not yet recovered.
The current ABEO drawdown is -99.99%.
Since Nov 1, 1999 ABEO has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100.00% | Mar 6, 2000 | 5582 | May 11, 2022 | Ongoing | Ongoing | Ongoing |
| -44.74% | Nov 1, 1999 | 22 | Dec 2, 1999 | 26 | Jan 10, 2000 | 48 |
| -19.15% | Jan 24, 2000 | 2 | Jan 26, 2000 | 12 | Feb 11, 2000 | 14 |
| -17.81% | Feb 22, 2000 | 5 | Feb 29, 2000 | 2 | Mar 2, 2000 | 7 |
| -16.98% | Feb 11, 2000 | 2 | Feb 15, 2000 | 2 | Feb 17, 2000 | 4 |
| -1.56% | Jan 13, 2000 | 3 | Jan 19, 2000 | 2 | Jan 21, 2000 | 5 |